TechcelerateJoin now
Menu
Past member company

Doc Abode

Real-time clinician deployment for the NHS: matching patient need to available clinical capacity.

Doc Abode logo

Doc Abode is a real-time clinician deployment platform. It dynamically matches patient need to available clinical capacity, helping NHS services respond faster and keep people out of hospital.

What it does

  • Dynamic scheduling: organises multidisciplinary teams for urgent, prioritised responses.
  • Planned care scheduling: reduces the scheduling burden of care plans for NHS teams.
  • On-demand scheduling: a same-day demand management module that extends access to more clinicians during escalations.
  • Vaccine scheduling.

Who it is for

  • Healthcare providers: manage workforce logistics digitally through a web portal.
  • Clinicians: contribute to healthcare services on their own terms, through a secure smartphone app.
  • NHS services: case studies include CNWL NHS Foundation Trust and Conexus Healthcare GP Federation.

Impact

A 50% increase in Urgent Community Response service capacity and workforce productivity, and agency spend eliminated at a leading London-based provider.

NatWest IP-backed growth funding

In 2026 Doc Abode secured IP-backed growth funding from NatWest, a loan that unlocks the value of the company’s intellectual property. It will help Doc Abode invest in implementation capacity, customer success and ongoing product development as it supports more NHS trusts. As Taz puts it: “As a GP, I’ve seen the human cost of poor coordination… This funding accelerates our ability to scale a better way of working.”

  • Results: a Health Innovation Network case study reports a 120% increase in patient visits per shift and agency spend eliminated at participating trusts.
  • NHS adoption: part of the North Central London ICB programme, with UCLPartners evaluating the platform across multiple NHS trusts.
  • SBRI Healthcare: a £499,971 Phase 3 award.

Read more: Health tech platform Doc Abode secures NatWest IP-backed growth funding (NatWest Group).

One to Watch

Founder and CEO Dr Taz Aldawoud is named one of the Ones to Watch in the LDC Top 50 2026, supported by The Times.

Founded in 2016 by Dr Taz Aldawoud, a GP. Backed by NatWest IP-backed growth funding, SBRI Healthcare, the AWS Healthcare Accelerator and the Momentum Fund. Doc Abode was part of the Techcelerate Health Tech Cluster.

On the Techcelerate blog

1 post mentioning Doc Abode.

Building a tech company?

Join tech founders who put execution before investment.

Become a member